Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 9 of 9

Publication Record

Connections

Compressive fatigue and fracture toughness behavior of injectable, settable bone cements.
Harmata AJ, Uppuganti S, Granke M, Guelcher SA, Nyman JS
(2015) J Mech Behav Biomed Mater 51: 345-55
MeSH Terms: Bone Cements, Compressive Strength, Elasticity, Injections, Materials Testing, Stress, Mechanical
Show Abstract · Added August 27, 2015
Bone grafts used to repair weight-bearing tibial plateau fractures often experience cyclic loading, and there is a need for bone graft substitutes that prevent failure of fixation and subsequent morbidity. However, the specific mechanical properties required for resorbable grafts to optimize structural compatibility with native bone have yet to be established. While quasi-static tests are utilized to assess weight-bearing ability, compressive strength alone is a poor indicator of in vivo performance. In the present study, we investigated the effects of interfacial bonding on material properties under conditions that re-capitulate the cyclic loading associated with weight-bearing fractures. Dynamic compressive fatigue properties of polyurethane (PUR) composites made with either unmodified (U-) or polycaprolactone surface-modified (PCL-) 45S5 bioactive glass (BG) particles were compared to a commercially available calcium sulfate and phosphate-based (CaS/P) bone cement at physiologically relevant stresses (5-30 MPa). Fatigue resistance of PCL-BG/polymer composite was superior to that of the U-BG/polymer composite and the CaS/P cement at higher stress levels for each of the fatigue failure criteria, related to modulus, creep, and maximum displacement, and was comparable to human trabecular bone. Steady state creep and damage accumulation occurred during the fatigue life of the PCL-BG/polymer and CaS/P cement, whereas creep of U-BG/polymer primarily occurred at a low number of loading cycles. From crack propagation testing, fracture toughness or resistance to crack growth was significantly higher for the PCL-BG composite than for the other materials. Finally, the fatigue and fracture toughness properties were intermediate between those of trabecular and cortical bone. These findings highlight the potential of PCL-BG/polyurethane composites as weight-bearing bone grafts.
Published by Elsevier Ltd.
2 Communities
3 Members
0 Resources
6 MeSH Terms
Detectable serum tobramycin levels in patients with renal dysfunction and recent placement of antibiotic-impregnated cement knee or hip spacers.
Noto MJ, Koethe JR, Miller G, Wright PW
(2014) Clin Infect Dis 58: 1783-4
MeSH Terms: Acute Kidney Injury, Aged, Aged, 80 and over, Anti-Bacterial Agents, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Bone Cements, Female, Humans, Male, Middle Aged, Prosthesis-Related Infections, Reoperation, Tobramycin
Added May 27, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
Acute kidney injury after placement of an antibiotic-impregnated cement spacer during revision total knee arthroplasty.
Menge TJ, Koethe JR, Jenkins CA, Wright PW, Shinar AA, Miller GG, Holt GE
(2012) J Arthroplasty 27: 1221-7.e1-2
MeSH Terms: Acute Kidney Injury, Aged, Aminoglycosides, Anti-Bacterial Agents, Arthroplasty, Replacement, Knee, Bone Cements, Cohort Studies, Creatinine, Female, Humans, Incidence, Kidney, Knee Prosthesis, Male, Middle Aged, Prosthesis-Related Infections, Reoperation, Retrospective Studies, Tobramycin
Show Abstract · Added May 27, 2014
We performed a retrospective cohort study of 84 patients to determine the incidence and predictors of acute kidney injury after antibiotic-impregnated cement spacer (ACS) placement for infected total knee arthroplasties. Acute kidney injury was defined as a more than 50% rise in serum creatinine from a preoperative baseline to a level greater than 1.4 mg/dL within 90 days postoperatively. Total incidence was 17% (n = 14; 95% confidence interval [CI], 10%-26%), and acute kidney injury was significantly associated with ACS tobramycin dose as both a dichotomous variable (>4.8 g; odds ratio, 5.87; 95% CI, 1.43-24.19; P = .01) and linear variable (odds ratio, 1.24 for every 1-g increase; 95% CI, 1.00-1.52; P = .049). Routine monitoring of serum creatinine and measurement of serum aminoglycoside levels in response to a threshold creatinine rise may be warranted after the placement of an aminoglycoside-containing ACS.
Copyright © 2012 Elsevier Inc. All rights reserved.
0 Communities
1 Members
0 Resources
19 MeSH Terms
Recurring osteoma within a calcium phosphate bone cement cranioplasty: case report.
Hayden MG, Guzman R, Dulai MS, Mobley BC, Edwards MS
(2009) Neurosurgery 64: E775-6; discussion E776
MeSH Terms: Bone Cements, Bone Neoplasms, Calcium Phosphates, Child, Humans, Male, Methylmethacrylate, Neoplasm Recurrence, Local, Osteoma, Radiography, Tomography Scanners, X-Ray Computed
Show Abstract · Added August 14, 2014
OBJECTIVE - We present a unique case of a recurrent osteoma within a cranioplasty performed with calcium phosphate bone cement.
CLINICAL PRESENTATION - The patient is a 7-year-old boy who had initially undergone a craniotomy for resection of a frontal cranial tumor followed by a cranioplasty with artificial bone matrix. On routine follow-up evaluation 2 years later, the patient had a mass expanding from the cranioplasty.
INTERVENTION - At the time of reoperation, the patient was found to have a histopathologically confirmed recurrent osteoma within the artificial bone matrix. The patient later underwent repair of the frontal cranial defect using a patient-specific implant.
CONCLUSION - We discuss this unusual case, treatment, and possible causes. We believe that a safety margin and curettage of the resection border as well as resection of the overlying periosteum might prevent recurrence.
0 Communities
1 Members
0 Resources
11 MeSH Terms
Biodegradable polyurethanes: synthesis and applications in regenerative medicine.
Guelcher SA
(2008) Tissue Eng Part B Rev 14: 3-17
MeSH Terms: Absorbable Implants, Animals, Biocompatible Materials, Bone Cements, Humans, Hydrogen Bonding, Materials Testing, Models, Chemical, Muscles, Nerve Regeneration, Polyurethanes, Regenerative Medicine, Surface Properties, Tissue Engineering, Wound Healing
Show Abstract · Added February 23, 2016
Biostable polyurethanes (PURs) have been incorporated in biomedical devices since the 1960s. The mechanisms of degradation and compositions with improved in vivo biostability have been investigated extensively. In recent years, biodegradable PURs have been investigated for applications in regenerative medicine. In contrast to the biostable implants, these biomaterials are designed to undergo controlled degradation in vivo and promote ingrowth of new tissue. Tissue-engineered scaffolds have been fabricated from biodegradable PURs using a variety of techniques, including thermally induced phase separation, salt leaching, wet spinning, electrospinning, and carbon dioxide foaming. These materials have been reported to support the ingrowth of cells and tissue in vitro and in vivo, and undergo controlled degradation to noncytotoxic decomposition products. Due to their tunable biological, mechanical, and physicochemical properties, biodegradable PURs present compelling future opportunities as scaffolds for regeneration of tissue. This review article summarizes recent advances made in the synthesis of biodegradable PURs and the application of these materials as scaffolds for regenerative medicine.
1 Communities
1 Members
0 Resources
15 MeSH Terms
Treatment of chronic symptomatic vertebral compression fractures with percutaneous vertebroplasty.
Brown DB, Gilula LA, Sehgal M, Shimony JS
(2004) AJR Am J Roentgenol 182: 319-22
MeSH Terms: Adult, Aged, Aged, 80 and over, Back Pain, Bone Cements, Chronic Disease, Cohort Studies, Female, Humans, Injections, Spinal, Lumbar Vertebrae, Male, Methylmethacrylate, Middle Aged, Recovery of Function, Retrospective Studies, Spinal Fractures, Thoracic Vertebrae, Time Factors, Treatment Outcome
Show Abstract · Added March 5, 2014
OBJECTIVE - Most fractures treated with percutaneous vertebroplasty are subacute and less than 1 year old. We report our experience treating chronic vertebral fractures with vertebroplasty.
MATERIALS AND METHODS - Our database identified 41 patients with symptomatic fractures more than 1 year old. These patients were categorized into subgroups determined by fracture age: 12 months 1 day-24 months (n = 16) or more than 24 months 1 day (n = 25). Changes in pain and mobility for the study group were compared with those in 49 patients with fractures less than 1 year old.
RESULTS - Thirty-three (80%) of the 41 patients in the study group had improvement in pain-seven (17%) had complete and 26 (63%) had partial relief. Forty-five (92%) of the 49 control group patients had improvement in pain-24 (49%) had complete and 21 (43%) had partial relief. The number of patients achieving partial or complete relief of pain was not statistically different between groups (p > 0.05), although complete relief was significantly more frequent in the control group (p = 0.002). Twenty patients (49%) in the study group versus 34 patients (69%) in the control group had improved mobility after vertebroplasty (p = 0.047). Patients with fractures 12 months 1 day-24 months old had improvement in mobility similar to that in patients in the control group (p = 0.962). Fractures more than 24 months 1 day old were associated with significantly less improvement in mobility (p = 0.006).
CONCLUSION - Most patients with fractures more than 1 year old will experience clinical benefit from vertebroplasty. Complete relief of pain is more likely when less mature fractures are treated.
0 Communities
1 Members
0 Resources
20 MeSH Terms
Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors.
York JE, Walsh GL, Lang FF, Putnam JB, McCutcheon IE, Swisher SG, Komaki R, Gokaslan ZL
(1999) J Neurosurg 91: 74-80
MeSH Terms: Adenocarcinoma, Adult, Aged, Bone Cements, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Female, Follow-Up Studies, Humans, Laminectomy, Lung Neoplasms, Male, Methylmethacrylate, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Neoplasm Staging, Neoplasms, Second Primary, Orthopedic Fixation Devices, Orthopedic Procedures, Pain, Pancoast Syndrome, Pneumonectomy, Spinal Neoplasms, Spine, Thoracic Neoplasms, Thoracic Surgical Procedures, Thoracotomy
Show Abstract · Added March 27, 2014
OBJECT - Traditionally, superior sulcus tumors of the lung that involve the chest wall and spinal column have been considered to be unresectable, and historically, patients harboring these tumors have been treated with local radiation therapy with, at best, modest results. The value of gross-total resection remains unclear in this patient population; however, with the recent advances in surgical technique and spinal instrumentation, procedures involving more radical removal of such tumors are now possible. At The University of Texas M. D. Anderson Cancer Center, the authors have developed a new technique for resecting superior sulcus tumors that invade the chest wall and spinal column. They present a technical description of this procedure and results in nine patients in whom stage IIIb superior sulcus tumors extensively invaded the vertebral column.
METHODS - These patients underwent gross-total tumor resection via a combined approach that included posterolateral thoracotomy, apical lobectomy, chest wall resection, laminectomy, vertebrectomy, anterior spinal column reconstruction with methylmethacrylate, and placement of spinal instrumentation. There were six men and three women, with a mean age of 55 years (range 36-72 years). Histological examination revealed squamous cell carcinoma (three patients), adenocarcinoma (four patients), and large cell carcinoma (two patients). The mean postoperative follow-up period was 16 months. All patients are currently ambulatory or remained ambulatory until they died. Pain related to tumor invasion improved in four patients and remained unchanged in five. In three patients instrumentation failed and required revision. There was one case of cerebrospinal fluid leakage that was treated with lumbar drainage and one case of wound breakdown that required revision. Two patients experienced local tumor recurrence, and one patient developed a second primary lung tumor.
CONCLUSIONS - The authors conclude that in selected patients, combined radical resection of superior sulcus tumors of the lung that involve the chest wall and spinal column may represent an acceptable treatment modality that can offer a potential cure while preserving neurological function and providing pain control.
0 Communities
1 Members
0 Resources
28 MeSH Terms
The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty.
Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M
(1999) J Arthroplasty 14: 339-46
MeSH Terms: Anti-Bacterial Agents, Arthroplasty, Replacement, Biomechanical Phenomena, Bone Cements, Humans, Materials Testing, Methicillin Resistance, Powders, Staphylococcus aureus, Tensile Strength, Tobramycin, Vancomycin
Show Abstract · Added March 13, 2015
We examined the effects of vancomycin on the compressive strength and fatigue life of bone cement and the pharmacokinetics and antimicrobial activity against methicillin-resistant Staphylococcus aureus of vancomycin eluted from bone cement, both alone and in combination with tobramycin. Two cements, Palacos and Simplex, were tested. Three antibiotic preparations were tested: lyophilized vancomycin (vancomycin-L), vancomycin powder (vancomycin-P), and tobramycin powder (Lilly, Indianapolis, IN). Although antibiotics did not significantly affect compressive strength, the fatigue life of bone cement was significantly decreased with vancomycin. Thus, fatigue testing revealed effects on cement strength not apparent by compression testing. Vancomycin-P had a substantially less detrimental effect on fatigue strength than vancomycin-L. Vancomycin-P elutes less efficiently than tobramycin. Although relatively little vancomycin-P eluted from bone cement, it retained biologic activity.
0 Communities
1 Members
0 Resources
12 MeSH Terms
Transthoracic vertebrectomy for metastatic spinal tumors.
Gokaslan ZL, York JE, Walsh GL, McCutcheon IE, Lang FF, Putnam JB, Wildrick DM, Swisher SG, Abi-Said D, Sawaya R
(1998) J Neurosurg 89: 599-609
MeSH Terms: Adult, Aged, Analgesics, Opioid, Back Pain, Bone Cements, Bone Plates, Bone Screws, Breast Neoplasms, Cervical Vertebrae, Female, Humans, Kidney Neoplasms, Kyphosis, Lumbar Vertebrae, Lung Neoplasms, Male, Melanoma, Methylmethacrylate, Methylmethacrylates, Middle Aged, Muscle Weakness, Pain Measurement, Pain, Intractable, Pulmonary Atelectasis, Pulmonary Embolism, Reconstructive Surgical Procedures, Retrospective Studies, Sarcoma, Spinal Neoplasms, Survival Rate, Thoracic Vertebrae, Treatment Outcome, Walking
Show Abstract · Added March 27, 2014
OBJECT - Anterior approaches to the spine for the treatment of spinal tumors have gained acceptance; however, in most published reports, patients with primary, metastatic, or chest wall tumors involving cervical, thoracic, or lumbar regions of the spine are combined. The purpose of this study was to provide a clear perspective of results that can be expected in patients who undergo anterior vertebral body resection, reconstruction, and stabilization for spinal metastases that are limited to the thoracic region.
METHODS - Outcome is presented for 72 patients with metastatic spinal tumors who were treated by transthoracic vertebrectomy at The University of Texas M. D. Anderson Cancer Center. The predominant primary tumors included renal cancer in 19 patients, breast cancer in 10, melanoma or sarcoma in 10, and lung cancer in nine patients. The most common presenting symptoms were back pain, which occurred in 90% of patients, and lower-extremity weakness, which occurred in 64% of patients. All patients underwent transthoracic vertebrectomy, decompression, reconstruction with methylmethacrylate, and anterior fixation with locking plate and screw constructs. Supplemental posterior instrumentation was required in seven patients with disease involving the cervicothoracic or thoracolumbar junction, which was causing severe kyphosis. After surgery, pain improved in 60 of 65 patients. This improvement was found to be statistically significant (p < 0.001) based on visual analog scales and narcotic analgesic medication use. Thirty-five of the 46 patients who presented with neurological dysfunction improved significantly (p < 0.001) following the procedure. Thirty-three patients had weakness but could ambulate preoperatively. Seventeen of these 33 regained normal strength, 15 patients continued to have weakness, and one patient was neurologically worse postoperatively. Of the 13 preoperatively nonambulatory patients, 10 could walk after surgery and three were still unable to walk but showed improved motor function. Twenty-one patients had complications ranging from minor atelectasis to pulmonary embolism. The 30-day mortality rate was 3%. The 1-year survival rate for the entire study population was 62%.
CONCLUSIONS - These results suggest that transthoracic vertebrectomy and spinal stabilization can improve the quality of life considerably in cancer patients with spinal metastasis by restoring or preserving ambulation and by controlling intractable spinal pain with acceptable rates of morbidity and mortality.
0 Communities
1 Members
0 Resources
33 MeSH Terms